Showing results (1621-1630 of 1,729) with videos related to

Sort By:
Pageof 173
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancerP Harter, F Trillsch, A Okamoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trialI Ray-Coquard, A Leary, S Pignata, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 27, 2024
DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional ClassificationPhilipp Jurmeister, Maximilian Leitheiser, Alexander Arnold, et al.
Geburtshilfe Und Frauenheilkunde|April 8, 2025
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024)Markus Wallwiener, Marco Johannes Battista, Eike-Christian Burandt, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum productionLain-Yen Hu, Daniel Du, Jennifer Hoffman, et al.
Clinical Genitourinary Cancer|October 4, 2021
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) TrialStéphane Culine, Valentin Harter, Gwenaelle Gravis, et al.
Cell Reports. Medicine|June 12, 2025
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant gliomaYao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2025
Clinical potential of [18F]FET PET in patients with circumscribed astrocytic gliomaJan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
The Plant Genome|January 16, 2026
Potato dihaploids uncover diverse alleles to facilitate diploid potato breedingSapphire Coronejo, Brieanne Vaillancourt, John P Hamilton, et al.
Pageof 173